Evidence map›Paper›PMID 30799682›Full record

ArticleMolecular imaging

PET Imaging of Hepatocellular Carcinomas:

Jing Zhao, Zhanwen Zhang, Dahong Nie, Hui Ma, Gongjun Yuan, Shu Su, Shaoyu Liu, Sheng Liu, Ganghua Tang

Abstract read
In one paragraph

Article in Molecular imaging. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. 2-[Molecular imaging and biology · 2025
    Article
  2. Review
  3. Article
  4. Synthesis and Evaluation ofMolecules (Basel, Switzerland) · 2022
    Article
  5. Propionic Acid-Based PET Imaging of Prostate Cancer.Molecular imaging and biology · 2021
    Article
  6. Review
  7. Article
  8. Validation of R-2-[Molecular imaging and biology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing Zhao1 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou, China.
Zhanwen Zhang3 Guangdong Engineering Research Center for Translational Application of Medical Radiopharmaceuticals, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Dahong Nie3 Guangdong Engineering Research Center for Translational Application of Medical Radiopharmaceuticals, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Hui Ma3 Guangdong Engineering Research Center for Translational Application of Medical Radiopharmaceuticals, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Gongjun Yuan3 Guangdong Engineering Research Center for Translational Application of Medical Radiopharmaceuticals, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Shu Su3 Guangdong Engineering Research Center for Translational Application of Medical Radiopharmaceuticals, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Shaoyu Liu3 Guangdong Engineering Research Center for Translational Application of Medical Radiopharmaceuticals, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Sheng Liu1 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou, China.
Ganghua Tang3 Guangdong Engineering Research Center for Translational Application of Medical Radiopharmaceuticals, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the preclinical value of

methodsThe

resultsIn vitro experiments showed that the radiotracer uptake patterns were complementary in the HCC cell lines. Orlistat and 5-tetradecyloxy-2-furoic acid decreased the uptake of

conclusionsPET imaging with

Indexed as

AnimalsCarcinoma, HepatocellularCell Line, TumorFatty Acid Synthase, Type IFluorodeoxyglucose F18Glucose Transporter Type 1Hep G2 CellsHumansLiver NeoplasmsMatrix Metalloproteinase 2MiceNeoplasm TransplantationOrlistatPositron-Emission TomographyPropionatesRadiopharmaceuticalsFASN protein, humanFatty Acid Synthase, Type IFluorodeoxyglucose F18Glucose Transporter Type 1Matrix Metalloproteinase 2MMP2 protein, humanOrlistatPropionatespropionic acidRadiopharmaceuticalsSLC2A1 protein, humanF-fluorodeoxyglucose (F-FDG)F-fluoropropionic acid (F-FPA)hepatocellular carcinoma (HCC)positron emission tomography (PET)

Identifiers

PMID30799682
PMCPMC6322104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.